Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Karius
company
About
Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions.
- Redwood City,California,United States
- 101 - 250
- https://kariusdx.com
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $165M
- Industries
- Biotechnology,Genetics,Health Care,Information Technology,Life Science
- Founded date
- Jan 1, 2014
- Number Of Employee
- 101 - 250
- Operating Status
- Active
- Legal Name
- Karius, Inc.
Karius is a life sciences company focused on generating genomic insights for infectious diseases with a liquid biopsy for infectious diseases. The Karius Test that helps clinicians make rapid, treatment decisions. By mapping each patient’s microbial landscape from a single blood draw, Karius moves closer to a vision of a world where infectious disease is no longer a major threat to human health. The Karius laboratory is CLIA-certified and CAP-accredited to perform high-complexity clinical laboratory testing.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
6
$254M
Karius has raised a total of
$254M
in funding over 2 rounds. Their latest funding was raised on
Mar 7, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 7, 2022 | Series B | — | 2 | — | — | Detail |
| Jan 20, 2021 | Series B | — | 1 | — | — | Detail |
| Feb 24, 2020 | Series B | $165M | 5 |
SoftBank Vision Fund
|
— | Detail |
| Nov 30, 2018 | Debt Financing | $25M | 1 |
|
— | Detail |
| Aug 5, 2017 | Series A | $59M | 8 |
DCVC
Lightspeed Venture Partners
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
5
13
Karius is funded by 13 investors.
SoftBank Vision Fund
and Oxford Finance LLC
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
SoftBank Vision Fund
|
Yes | Series B |
|
|
Yes | Debt Financing |
|
DCVC
|
Yes | Series A |
HBM Healthcare Investments AG
|
— | Series B |
HBM Partners
|
— | Series B |
General Catalyst
|
— | Series B |
Khosla Ventures
|
— | Series B |
|
Lightspeed Venture Partners
|
— | Series B |
aMoon Fund
|
— | Series A |
Innovation Endeavors
|
— | Series A |
Employee Profiles
Number of Employee Profiles
13
Karius has 13 current employee profiles, including
Board member Alexander Morgan
Board member
Board member
Executive
Advisor
Advisor
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
